| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Alireza Mashaghi | Q30505649 |
| Takenori Inomata | Q55536161 | ||
| Farsad Noorizadeh | Q60669541 | ||
| P2093 | author name string | Kevin Wu | |
| Mostafa Heidari | |||
| P2860 | cites work | Mucosal environmental sensors in the pathogenesis of dry eye. | Q46859273 |
| Alpha-lipoic acid restores tear production in an animal model of dry eye. | Q46950481 | ||
| Mitochondria-Targeted Antioxidant SkQ1 Prevents Anesthesia-Induced Dry Eye Syndrome. | Q47093888 | ||
| Comparison of Tear Meniscus Height Measurements Obtained With the Keratograph and Fourier Domain Optical Coherence Tomography in Dry Eye. | Q47369232 | ||
| Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay | Q47374338 | ||
| RNA Collection From Human Conjunctival Epithelial Cells Obtained With a New Device for Impression Cytology | Q47397638 | ||
| Foundations of Immunometabolism and Implications for Metabolic Health and Disease | Q47772688 | ||
| Changes in Distribution of Dry Eye Disease by the New 2016 Diagnostic Criteria from the Asia Dry Eye Society. | Q48138863 | ||
| IFN-γ-Expressing Th17 Cells Are Required for Development of Severe Ocular Surface Autoimmunity. | Q48240995 | ||
| Generating minicorneal organoids from human induced pluripotent stem cells | Q48355403 | ||
| Corneal Tissue From Dry Eye Donors Leads to Enhanced Graft Rejection. | Q50098128 | ||
| Comparison of Topical Application of TSG-6, Cyclosporine, and Prednisolone for Treating Dry Eye. | Q50233079 | ||
| Characterization of human reflex tear proteome reveals high expression of lacrimal proline-rich protein 4 (PRR4). | Q50954936 | ||
| Tissue models: a living system on a chip. | Q51549876 | ||
| Assessment of Lower Tear Meniscus. | Q51750868 | ||
| Microbial ecology of the gastrointestinal tract | Q22255628 | ||
| Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine | Q26740411 | ||
| The healthy human microbiome | Q26749316 | ||
| The Treg/Th17 Axis: A Dynamic Balance Regulated by the Gut Microbiome | Q26770669 | ||
| Associations between signs and symptoms of dry eye disease: a systematic review | Q26781979 | ||
| Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells | Q29618126 | ||
| Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation | Q29620116 | ||
| Impact of dry eye syndrome on vision-related quality of life in a non-clinic-based general population | Q31072475 | ||
| The Growing Need for Validated Biomarkers and Endpoints for Dry Eye Clinical Research | Q33756582 | ||
| In vivo confocal microscopy of meibomian glands in Sjögren's syndrome. | Q33775348 | ||
| The importance of the ratio of omega-6/omega-3 essential fatty acids | Q33962634 | ||
| Meibum lipid composition in Asians with dry eye disease | Q34063529 | ||
| Tear proteomic analysis of Sjögren syndrome patients with dry eye syndrome by two-dimensional-nano-liquid chromatography coupled with tandem mass spectrometry | Q34091841 | ||
| Diagnosing the severity of dry eye: a clear and practical algorithm | Q34092386 | ||
| Desiccating stress-induced chemokine expression in the epithelium is dependent on upregulation of NKG2D/RAE-1 and release of IFN-γ in experimental dry eye. | Q34476263 | ||
| The effects of 3% diquafosol sodium eye drop application on meibomian gland and ocular surface alterations in the Cu, Zn-superoxide dismutase-1 (Sod1) knockout mice. | Q51766966 | ||
| Health Sensors, Smart Home Devices, and the Internet of Medical Things: An Opportunity for Dramatic Improvement in Care for the Lower Extremity Complications of Diabetes. | Q52595737 | ||
| Effects of eye drops containing a mixture of omega-3 essential fatty acids and hyaluronic acid on the ocular surface in desiccating stress-induced murine dry eye. | Q52647972 | ||
| Expression of Lipid Peroxidation Markers in the Tear Film and Ocular Surface of Patients with Non-Sjogren Syndrome: Potential Biomarkers for Dry Eye Disease. | Q53177612 | ||
| Comparison of Self-applied Heat Therapy for Meibomian Gland Dysfunction. | Q53241470 | ||
| Dexamethasone nanowafer as an effective therapy for dry eye disease. | Q53422132 | ||
| Evaluation of dry eye and meibomian gland dysfunction with meibography in patients with rosacea. | Q53560775 | ||
| Pathological conversion of regulatory T cells is associated with loss of allotolerance. | Q55064864 | ||
| Maximum blink interval is associated with tear film breakup time: A new simple, screening test for dry eye disease | Q58759867 | ||
| The use of in-strip digestion for fast proteomic analysis on tear fluid from dry eye patients | Q58802532 | ||
| Effects of Sequential Artificial Tear and Cyclosporine Emulsion Therapy on Conjunctival Goblet Cell Density and Transforming Growth Factor-β2 Production | Q61851319 | ||
| Microbiome Dependent Regulation of T and Th17 Cells in Mucosa | Q64114415 | ||
| Interplay Between the Host, the Human Microbiome, and Drug Metabolism. | Q64996610 | ||
| Ophthalmic cyclosporine use in ocular GVHD | Q79320052 | ||
| Evaluation of oxidative stress levels in the conjunctival epithelium of patients with or without dry eye, and dry eye patients treated with preservative-free hyaluronic acid 0.15 % and vitamin B12 eye drops | Q85965168 | ||
| Diclofenac protects cultured human corneal epithelial cells against hyperosmolarity and ameliorates corneal surface damage in a rat model of dry eye | Q87542863 | ||
| Metabolism as a Target for Modulation in Autoimmune Diseases | Q88607770 | ||
| Risk Factors for Severe Dry Eye Disease: Crowdsourced Research Using DryEyeRhythm | Q90501872 | ||
| The immunoregulatory role of corneal epithelium-derived thrombospondin-1 in dry eye disease | Q90586597 | ||
| Microbiota and metabolites in metabolic diseases | Q90854256 | ||
| Multiscale reverse engineering of the human ocular surface | Q92432885 | ||
| Bringing microbiome-drug interaction research into the clinic | Q92450459 | ||
| Mapping human microbiome drug metabolism by gut bacteria and their genes | Q92491606 | ||
| Tear meniscus evaluation by anterior segment swept-source optical coherence tomography | Q44633370 | ||
| Biomarkers in Ocular Chronic Graft Versus Host Disease: Tear Cytokine- and Chemokine-Based Predictive Model. | Q44820020 | ||
| Gene Expression-Based Predictive Models of Graft Versus Host Disease-Associated Dry Eye. | Q46136286 | ||
| Topical Fluorometholone Protects the Ocular Surface of Dry Eye Patients from Desiccating Stress: A Randomized Controlled Clinical Trial. | Q46213404 | ||
| Contact lens to measure individual ion concentrations in tears and applications to dry eye disease. | Q46252481 | ||
| Dry eye disease and oxidative stress. | Q46317252 | ||
| Mitochondrial DNA oxidation induces imbalanced activity of NLRP3/NLRP6 inflammasomes by activation of caspase-8 and BRCC36 in dry eye. | Q46412408 | ||
| Microbiota-Dependent Activation of an Autoreactive T Cell Receptor Provokes Autoimmunity in an Immunologically Privileged Site | Q34490115 | ||
| The microbiota in adaptive immune homeostasis and disease | Q34533142 | ||
| Sensitivity and specificity of a point-of-care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye. | Q34544207 | ||
| Chemokine receptors CCR6 and CXCR3 are necessary for CD4(+) T cell mediated ocular surface disease in experimental dry eye disease | Q35040958 | ||
| Epidemiology of dry eye syndrome. | Q35076489 | ||
| Prospective, multicenter, clinical evaluation of point-of-care matrix metalloproteinase-9 test for confirming dry eye disease | Q35197785 | ||
| Considerations in understanding the ocular surface microbiome | Q35226810 | ||
| Oral omega-3 fatty acids treatment in computer vision syndrome related dry eye. | Q35564285 | ||
| Immunomodulatory cross-talk between conjunctival goblet cells and dendritic cells | Q35582470 | ||
| Proteomics Differentiate Between Thyroid-Associated Orbitopathy and Dry Eye Syndrome | Q35591590 | ||
| Oxidative stress markers induced by hyperosmolarity in primary human corneal epithelial cells | Q35646417 | ||
| Dry eye disease in type 2 diabetes mellitus; comparison of the tear osmolarity test with other common diagnostic tests: a diagnostic accuracy study using STARD standard | Q35655252 | ||
| Gut biogeography of the bacterial microbiota | Q35820919 | ||
| IL-13 Stimulates Proliferation and Expression of Mucin and Immunomodulatory Genes in Cultured Conjunctival Goblet Cells | Q35831266 | ||
| Evaluation of point-of-care test for elevated tear matrix metalloproteinase 9 in post-LASIK dry eyes. | Q35872889 | ||
| Expression of SIRT1 and oxidative stress in diabetic dry eye. | Q35919611 | ||
| Agreement between Automated and Traditional Measures of Tear Film Breakup | Q35995467 | ||
| Longitudinal changes in tear fluid lipidome brought about by eyelid-warming treatment in a cohort of meibomian gland dysfunction | Q36197694 | ||
| Analysis of Th17-associated cytokines and clinical correlations in patients with dry eye disease | Q36335761 | ||
| Aqueous Tear Deficiency Increases Conjunctival Interferon-γ (IFN-γ) Expression and Goblet Cell Loss | Q36345503 | ||
| Ocular surface extracellular DNA and nuclease activity imbalance: a new paradigm for inflammation in dry eye disease | Q36474926 | ||
| The interblink interval in normal and dry eye subjects | Q36590746 | ||
| Altered Mucosal Microbiome Diversity and Disease Severity in Sjögren Syndrome | Q36806556 | ||
| Dry Eye Profiles in Patients with a Positive Elevated Surface Matrix Metalloproteinase 9 Point-of-Care Test Versus Negative Patients. | Q36829070 | ||
| Inflammatory Response to Lipopolysaccharide on the Ocular Surface in a Murine Dry Eye Model. | Q36872927 | ||
| The CCR6/CCL20 axis mediates Th17 cell migration to the ocular surface in dry eye disease | Q36926074 | ||
| Interferon-γ-Induced Unfolded Protein Response in Conjunctival Goblet Cells as a Cause of Mucin Deficiency in Sjögren Syndrome | Q36990222 | ||
| Dexamethasone Drug Eluting Nanowafers Control Inflammation in Alkali-Burned Corneas Associated With Dry Eye. | Q37055739 | ||
| CD8⁺ cells regulate the T helper-17 response in an experimental murine model of Sjögren syndrome | Q37407580 | ||
| Tear lipid layer thickness with eye drops in meibomian gland dysfunction | Q37409792 | ||
| Lipidomic analysis of human tear fluid reveals structure-specific lipid alterations in dry eye syndrome | Q37457256 | ||
| Impaired Function of Peripherally Induced Regulatory T Cells in Hosts at High Risk of Graft Rejection | Q37529334 | ||
| Rapamycin Eye Drops Suppress Lacrimal Gland Inflammation In a Murine Model of Sjögren's Syndrome. | Q37610134 | ||
| Randomized, masked, in vitro comparison of three commercially available tear film osmometers | Q37623843 | ||
| Linking oxidative stress to inflammation: Toll-like receptors | Q37677270 | ||
| T Cell-Derived Granulocyte-Macrophage Colony-Stimulating Factor Contributes to Dry Eye Disease Pathogenesis by Promoting CD11b+ Myeloid Cell Maturation and Migration | Q37686712 | ||
| Immunometabolic Regulation of Interleukin-17-Producing T Helper Cells: Uncoupling New Targets for Autoimmunity. | Q37712496 | ||
| Dry eye in the beaver dam offspring study: prevalence, risk factors, and health-related quality of life | Q37715859 | ||
| Osmolality and tear film dynamics. | Q37948822 | ||
| Current and future challenges in primary Sjögren's syndrome | Q37972343 | ||
| Pharmacokinetic evaluation of diquafosol tetrasodium for the treatment of Sjögren's syndrome | Q38209468 | ||
| Extrathyroidal manifestations of Graves' disease: a 2014 update | Q38218911 | ||
| TFOS DEWS II Clinical Trial Design Report | Q38652975 | ||
| TFOS DEWS II Epidemiology Report | Q38652994 | ||
| TFOS DEWS II Definition and Classification Report. | Q38665717 | ||
| Treg-recruiting microspheres prevent inflammation in a murine model of dry eye disease. | Q38787674 | ||
| Modern approaches to the ocular delivery of cyclosporine A. | Q38808718 | ||
| Human tear proteomics and peptidomics in ophthalmology: Toward the translation of proteomic biomarkers into clinical practice. | Q38835672 | ||
| Global Metabonomic and Proteomic Analysis of Human Conjunctival Epithelial Cells (IOBA-NHC) in Response to Hyperosmotic Stress | Q38844758 | ||
| A guide to immunometabolism for immunologists. | Q38891307 | ||
| Reactive oxygen species activated NLRP3 inflammasomes initiate inflammation in hyperosmolarity stressed human corneal epithelial cells and environment-induced dry eye patients | Q38907526 | ||
| Clinical trials and systematic reviews addressing similar interventions for the same condition do not consider similar outcomes to be important: a case study in HIV/AIDS. | Q38935225 | ||
| Single unit filter-aided method for fast proteomic analysis of tear fluid | Q39019383 | ||
| LFA-1/ICAM-1 Interaction as a Therapeutic Target in Dry Eye Disease | Q39025675 | ||
| Evaluation of Meibomian Gland Dysfunction and Local Distribution of Meibomian Gland Atrophy by Non-contact Infrared Meibography | Q39110441 | ||
| Metabolic regulation of inflammation | Q39194474 | ||
| Innovation in the pharmaceutical industry: New estimates of R&D costs | Q39194484 | ||
| Precision and accuracy of TearLab osmometer in measuring osmolarity of salt solutions. | Q39207493 | ||
| Immunometabolism in systemic lupus erythematosus | Q39209701 | ||
| Fine tuning of immunometabolism for the treatment of rheumatic diseases | Q39223057 | ||
| Organ-on-a-chip devices advance to market | Q39375469 | ||
| TFOS DEWS II Introduction. | Q39453315 | ||
| Dry Eye Disease Is Already Present in Hematological Patients Before Hematopoietic Stem Cell Transplantation | Q40064942 | ||
| Infrared imaging of meibomian glands and evaluation of the lipid layer in Sjögren's syndrome patients and nondry eye controls. | Q40248527 | ||
| Predictors of Discordance between Symptoms and Signs in Dry Eye Disease | Q40407061 | ||
| A Randomized, Double-Masked, Placebo-Controlled Clinical Trial of Two Forms of Omega-3 Supplements for Treating Dry Eye Disease. | Q40462210 | ||
| Tear Cytokines as Biomarkers for Chronic Graft-versus-Host Disease | Q40612184 | ||
| Interaction of IFN-γ with cholinergic agonists to modulate rat and human goblet cell function. | Q41386825 | ||
| Anterior Segment Optical Coherence Tomography for Tear Meniscus Evaluation and its Correlation with other Tear Variables in Healthy Individuals | Q42054806 | ||
| Cornea organoids from human induced pluripotent stem cells. | Q42327814 | ||
| IL-17 Augments B Cell Activation in Ocular Surface Autoimmunity | Q42737501 | ||
| Treatment of ocular graft-versus-host disease with topical cyclosporine 0.05%. | Q42905232 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 9 | |
| P921 | main subject | eye disease | Q3041498 |
| P577 | publication date | 2019-09-11 | |
| P1433 | published in | Journal of Clinical Medicine | Q27724774 |
| P1476 | title | Dry Eye Disease: Emerging Approaches to Disease Analysis and Therapy | |
| P478 | volume | 8 |
| Q100945976 | Diagnostic ability of maximum blink interval together with Japanese version of Ocular Surface Disease Index score for dry eye disease |
| Q97643528 | The closed eye harbours a unique microbiome in dry eye disease |
| Q89783334 | Why Internists Should Care About Dry Eye Disease |
Search more.